Study: GAL-001: Adaptive Phase II in Refractory Melanoma
Phase II
· Site: Mount Halifax Oncology Center (Dr. A. Reyes)
· consented 2026-04-30
Adverse events
1
Serious AEs
0
Open data queries
0
Luna dropout signal
+0.0
Adverse events
mild
assessed
2026-08-18
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-04-24 (study day 19); relationship: not assessed
Data queries
weight_kg
auto_resolved
Missing value at Visit 3; source document shows 72 kg.
Auto-resolved: deterministic discrepancy in field "weight_kg" corrected against source rules. Flagged for audit trail.
☾ Luna engagement
Messages
4
Escalations
0
Check-ins
1
Mood ø
4.0
Med adherence · 7d
86%
Last check-in
2026-08-18
📅 Next appointment: Cycle 5 infusion — NXC-101
on 2026-08-20